Enzalutamide (formerly MDV3100) prolongs survival in docetaxel-pretreated castration-resistant prostate cancer patients

por Heck, Matthias M., Gschwend, Jürgen E., Retz, Margitta
Publicado 2013

Vinflunine in routine clinical practice for the treatment of advanced or metastatic urothelial cell carcinoma - data from a prospective, multicenter experience

por Retz, Margitta, de Geeter, Patrick, Goebell, Peter J., Matz, Ullrich, de Schultz, Wito, Hegele, Axel
Publicado 2015

S6K1 and 4E-BP1 Are Independent Regulated and Control Cellular Growth in Bladder Cancer

por Nawroth, Roman, Stellwagen, Florian, Schulz, Wolfgang A., Stoehr, Robert, Hartmann, Arndt, Krause, Bernd J., Gschwend, Juergen E., Retz, Margitta
Publicado 2011

Antimicrobial peptides of the Cecropin-family show potent antitumor activity against bladder cancer cells

por Suttmann, Henrik, Retz, Margitta, Paulsen, Friedrich, Harder, Jürgen, Zwergel, Ulrike, Kamradt, Jörn, Wullich, Bernd, Unteregger, Gerhard, Stöckle, Michael, Lehmann, Jan
Publicado 2008

Both radiographical and pathological lymph node statuses are independent predictors for survival following neoadjuvant chemotherapy and radical cystectomy for cT3/4 or cN+ bladder...

por Wagner, Julia, Simon, Ricarda, Büchler, Jakob Wolf, Kirchhoff, Florian, Kehl, Viktoria, Retz, Margitta, Gschwend, Juergen Erich, Sauter, Andreas, Horn, Thomas
Publicado 2022

A Phase II, single-arm study of nivolumab in patients with metastatic or unresectable urothelial cancer who have progressed following treatment with a platinum agent

por Sharma, Padmanee, Grimm, Marc-Oliver, Galsky, Matthew D, Baron, Ari, Bracarda, Sergio, Siefker-Radtke, Arlene, Lambert, Alexandre, Azrilevich, Alex, Retz, Margitta
Publicado 2015

Expression of human beta-defensins 1 and 2 in kidneys with chronic bacterial infection

por Lehmann, Jan, Retz, Margitta, Harder, Jürgen, Krams, Matthias, Kellner, Udo, Hartmann, Julia, Hohgräwe, Kerstin, Raffenberg, Uta, Gerber, Martin, Loch, Tillmann, Weichert-Jacobsen, Klaus, Stöckle, Michael
Publicado 2002

Categorical versus continuous circulating tumor cell enumeration as early surrogate marker for therapy response and prognosis during docetaxel therapy in metastatic prostate cancer...

por Thalgott, Mark, Rack, Brigitte, Eiber, Matthias, Souvatzoglou, Michael, Heck, Matthias M., Kronester, Caroline, Andergassen, Ulrich, Kehl, Victoria, Krause, Bernd J., Gschwend, Jurgen E., Retz, Margitta, Nawroth, Roman
Publicado 2015

Parallel PI3K, AKT and mTOR inhibition is required to control feedback loops that limit tumor therapy

por Sathe, Anuja, Chalaud, Géraldine, Oppolzer, Immanuel, Wong, Kit Yeng, von Busch, Margarita, Schmid, Sebastian C., Tong, Zhichao, Retz, Margitta, Gschwend, Juergen E., Schulz, Wolfgang A., Nawroth, Roman
Publicado 2018

Long-term results of a phase II study with neoadjuvant docetaxel chemotherapy and complete androgen blockade in locally advanced and high-risk prostate cancer

por Thalgott, Mark, Horn, Thomas, Heck, Matthias M, Maurer, Tobias, Eiber, Matthias, Retz, Margitta, Autenrieth, Michael, Herkommer, Kathleen, Krause, Bernd J, Gschwend, Jürgen E, Treiber, Uwe, Kübler, Hubert R
Publicado 2014

[(11)C]Choline PET/CT in therapy response assessment of a neoadjuvant therapy in locally advanced and high risk prostate cancer before radical prostatectomy

por Schwarzenböck, Sarah M., Knieling, Anna, Souvatzoglou, Michael, Kurth, Jens, Steiger, Katja, Eiber, Matthias, Esposito, Irene, Retz, Margitta, Kübler, Hubert, Gschwend, Jürgen E., Schwaiger, Markus, Krause, Bernd J., Thalgott, Mark
Publicado 2016

Cytoreductive radical prostatectomy after chemohormonal therapy in patients with primary metastatic prostate cancer

por Babst, Christa, Amiel, Thomas, Maurer, Tobias, Knipper, Sophie, Lunger, Lukas, Tauber, Robert, Retz, Margitta, Herkommer, Kathleen, Eiber, Matthias, von Amsberg, Gunhild, Graefen, Markus, Gschwend, Juergen, Steuber, Thomas, Heck, Matthias
Publicado 2022

A robust blood gene expression-based prognostic model for castration-resistant prostate cancer

por Wang, Li, Gong, Yixuan, Chippada-Venkata, Uma, Heck, Matthias Michael, Retz, Margitta, Nawroth, Roman, Galsky, Matthew, Tsao, Che-Kai, Schadt, Eric, de Bono, Johann, Olmos, David, Zhu, Jun, Oh, William K.
Publicado 2015

Radiation therapy before radical cystectomy combined with immunotherapy in locally advanced bladder cancer – study protocol of a prospective, single arm, multicenter phase II trial...

por Schmid, Sebastian C., Koll, Florestan J., Rödel, Claus, Maisch, Philipp, Sauter, Andreas, Beckert, Franziska, Seitz, Anna, Kübler, Hubert, Flentje, Michael, Chun, Felix, Combs, Stephanie E., Schiller, Kilian, Gschwend, Jürgen E., Retz, Margitta
Publicado 2020

A randomized, double-blind, placebo-controlled, Phase I/II trial of RNActive(®)-vaccine cv9104 in patients with metastatic castrate-refractory prostate cancer (mcrpc): first result...

por Koch, Sven D, Hong, Henoch, Feyerabend, Susan, Retz, Margitta, Kuebler, Hubert, Heidenreich, Axel, van Erps, Thomas, Schroeder, Andreas, Scheel, Birgit, Reus, Valérie, Kallen, Karl-Josef, Fotin-Mleczek, Mariola, Gnad-Vogt, Ulrike, Stenzl, Arnulf
Publicado 2014

Human papilloma virus is not detectable in samples of urothelial bladder cancer in a central European population: a prospective translational study

por Schmid, Sebastian C., Thümer, Leonore, Schuster, Tibor, Horn, Thomas, Kurtz, Florian, Slotta-Huspenina, Julia, Seebach, Judith, Straub, Michael, Maurer, Tobias, Autenrieth, Michael, Kübler, Hubert, Retz, Margitta, Protzer, Ulrike, Gschwend, Jürgen E., Hoffmann, Dieter
Publicado 2015

KLK3 and TMPRSS2 for molecular lymph-node staging in prostate cancer patients undergoing radical prostatectomy

por Lunger, Lukas, Retz, Margitta, Bandur, Miriam, Souchay, Marc, Vitzthum, Elisabeth, Jäger, Marion, Weirich, Gregor, Schuster, Tibor, Autenrieth, Michael, Kübler, Hubert, Maurer, Tobias, Thalgott, Mark, Herkommer, Kathleen, Koll, Florestan, Gschwend, Jürgen E., Nawroth, Roman, Heck, Matthias M.
Publicado 2020

German second-opinion network for testicular cancer: Sealing the leaky pipe between evidence and clinical practice

por ZENGERLING, FRIEDEMANN, HARTMANN, MICHAEL, HEIDENREICH, AXEL, KREGE, SUSANNE, ALBERS, PETER, KARL, ALEXANDER, WEISSBACH, LOTHAR, WAGNER, WALTER, BEDKE, JENS, RETZ, MARGITTA, SCHMELZ, HANS U., KLIESCH, SABINE, KUCZYK, MARKUS, WINTER, EVA, POTTEK, TOBIAS, DIECKMANN, KLAUS-PETER, SCHRADER, ANDRES JAN, SCHRADER, MARK
Publicado 2014

Analysis by region of outcomes for patients with advanced renal cell carcinoma treated with cabozantinib or everolimus: a sub-analysis of the METEOR study

por Schmidinger, Manuela, Motzer, Robert J., Rolland, Frederic, Staehler, Michael, Rink, Michael, Retz, Margitta, Csoszi, Tibor, McCaffrey, John A., De Giorgi, Ugo, Caserta, Claudia, Duran, Ignacio, Benzaghou, Fawzi, Clary, Douglas O., Albiges, Laurence, Choueiri, Toni K., Tannir, Nizar M.
Publicado 2022

Nivolumab plus rucaparib for metastatic castration-resistant prostate cancer: results from the phase 2 CheckMate 9KD trial

por Fizazi, Karim, Retz, Margitta, Petrylak, Daniel P, Goh, Jeffrey C, Perez-Gracia, Jose, Lacombe, Louis, Zschäbitz, Stefanie, Burotto, Mauricio, Mahammedi, Hakim, Gravis, Gwenaelle, Bastos, Diogo Assed, McCune, Steven L, Vázquez Limón, Juan Carlos, Kwan, Edmond M, Castellano, Daniel, Fléchon, Aude, Saad, Fred, Grimm, Marc-Oliver, Shaffer, David R, Armstrong, Andrew J, Bhagavatheeswaran, Prabhu, Amin, Neha P, Ünsal-Kaçmaz, Keziban, Wang, Xuya, Li, Jun, Loehr, Andrea, Pachynski, Russell K
Publicado 2022